临床决策对于慢性四肢威胁性缺血症患者
1Department of Cardiology, University of South Carolina School of Medicine Greenville, Prisma Health System, 701 Grove Road, Greenville, SC 29605, USA.
Advances in surgery
|August 6, 2025
概括
治疗慢性肢体威胁性缺血症 (CLTI) 需要重新血管化和感染控制. 开放式手术和内血管治疗都是对CLTI治疗的可行选择,根据患者个体因素进行选择.
科学领域:
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
- 血管内治疗疗法 血管内疗法
背景情况:
- 慢性四肢威胁性缺血症 (CLTI) 提出了复杂的治疗挑战.
- 患者经常有并发症,增加手术风险,缩短预期寿命.
- 及时的血管恢复,感染控制和监测是管理的关键组成部分.
研究的目的:
- 提供关于CLTI的诊断和管理的最新信息.
- 审查影响开放性手术 (OS) 和内血管治疗 (EVT) 之间的治疗决策的患者和病变特定因素.
- 为了对比常见的OS和EVT技术,并建议一个后续算法.
主要方法:
- 随机试验的综述,比较CLTI的OS和EVT.
- 对患者特异性和病变特异性特征的分析.
- 普遍存在的OS和EVT技术的比较.
- 开发一个建议的后续算法.
主要成果:
- 开放式手术和内血管治疗都是对CLTI的可行的治疗选择.
- 治疗选择取决于个体患者和病变特征.
- 随机试验支持OS和EVT的有效性.
结论:
- 最佳的CLTI治疗是个性化的,平衡OS与EVT的风险和益处.
- 仔细的患者和病变评估对于选择最合适的再血管化策略至关重要.
- 结构化的后续计划对于长期的CLTI管理至关重要.
相关概念视频
Peripheral Artery Disease IV: Nursing Management
44
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
44
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Peripheral Artery Disease V: Postoperative Nursing Management
25
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
25
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
Atherosclerosis IV: Nursing Management
51
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
51
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23


